Technology areas: Biotechnology & Pharmaceuticals • Medical Devices & Mechanical Engineering
11 pending office actions • 8 clients • 9 examiners • 7 art units • 0 of 11 (0%) have an AI response strategy ready • 7 patents granted in the last 365 days
NEW RIVER VALLEY INTELLECTUAL has 12 pending office actions in Medical Devices & Mechanical Engineering and 406 career applications. The profile reflects a current device-focused workload with a smaller historical application base.
The resolved allowance rate is 66.29%, and the average office actions per allowance is 4.16. The allowance measure shows that resolved matters reached allowance in a more limited portion of the record, while the action average indicates substantial examination effort for matters that did allow.
For practitioners, these figures support close attention to early claim drafting, technical evidence, and response sequencing. The active matters should be reviewed for recurring rejection themes and for opportunities to clarify the structural or functional features that distinguish the claimed devices.
Based on the USPTO statutory response window for each pending office action. 4 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 4 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 3 (27%) |
| §112 only | 2 (18%) |
| Double-patenting only | 1 (9%) |
| Multi-statute (no §101) | 5 (45%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| PEFFLEY, MICHAEL F | 2 | 77.8% | +13.5% |
| BARSKY, JARED | 2 | 50.3% | +22.8% |
| CLARK, RYAN T | 1 | 50.4% | +18.2% |
| ZHANG, YINGCHUAN | 1 | 68.9% | +28.4% |
| PETTITT, JOHN F | 1 | 25.9% | +21.6% |
| WILSON, MICHAEL C | 1 | 41.5% | +17.8% |
| LANNU, JOSHUA DARYL DEANON | 1 | 82.2% | +24.1% |
| KING, BRIAN M | 1 | 70.3% | +23.7% |
| COOK, LISA V | 1 | 67.5% | +10.3% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18404473 | DEVICES, SYSTEMS, AND METHODS FOR REAL-TIME MONITORING OF ELECTROPHYSICAL EFFECTS DURING TISSUE TREATMENT | LANNU, JOSHUA DARYL DEANON | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18315233 | LNG Liquefaction System and Process | KING, BRIAN M | 41d |
| 18890466 | MOVING TARGETS ROUTE SIMULATOR QUARTERBACK GAME | ZHANG, YINGCHUAN | — |
| 18792154 | LNG LIQUEFACTION SYSTEM AND PROCESS | PETTITT, JOHN F | — |
| 18680548 | FEL D 1 KNOCKOUTS AND ASSOCIATED COMPOSITIONS AND METHODS BASED ON CRISPR-CAS9 GENOMIC EDITING | WILSON, MICHAEL C | — |
| 18348605 | IMMUNOTHERAPEUTIC METHODS USING ELECTROPORATION | PEFFLEY, MICHAEL F | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18126561 | METHODS OF ADMINISTERING SOTALOL HYDROCHLORIDE | BARSKY, JARED | 125d overdue |
| 18417748 | METHOD OF INITIATING AND ESCALATING SOTALOL HYDROCHLORIDE DOSING | BARSKY, JARED | 121d overdue |
| 18608958 | CYCLED PULSING TO MITIGATE THERMAL DAMAGE FOR MULTI-ELECTRODE IRREVERSIBLE ELECTROPORATION THERAPY | PEFFLEY, MICHAEL F | 43d overdue |
| 18315233 | LNG Liquefaction System and Process | KING, BRIAN M | 41d |
| 18930252 | METHODS OF REDUCING ADVERSE EFFECTS OF NON-THERMAL ABLATION | CLARK, RYAN T | — |
| 18890466 | MOVING TARGETS ROUTE SIMULATOR QUARTERBACK GAME | ZHANG, YINGCHUAN | — |
| 18792154 | LNG LIQUEFACTION SYSTEM AND PROCESS | PETTITT, JOHN F | — |
| 18680548 | FEL D 1 KNOCKOUTS AND ASSOCIATED COMPOSITIONS AND METHODS BASED ON CRISPR-CAS9 GENOMIC EDITING | WILSON, MICHAEL C | — |
| Client (Assignee) | Pending OAs |
|---|---|
| Virginia Tech | 3 |
| AltaThera Pharmaceuticals | 2 |
| Mao, Shiwei | 1 |
| NuBlu Innovations, LLC | 1 |
| Indoor Biotechnologies Inc. | 1 |
| AngioDynamics | 1 |
| High Roller | 1 |
| David Kroeger | 1 |
| Art Unit | Apps |
|---|---|
| 3794 | 3 |
| 3763 | 2 |
| 1628 | 2 |
| 3711 | 1 |
| 1638 | 1 |
| 3791 | 1 |
| 1642 | 1 |
| App # | Title | Client | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|---|
| 18930252 | METHODS OF REDUCING ADVERSE EFFECTS OF NON-THERMAL ABLATION | VIRGINIA TECH INTELLECTUAL PROPERTIES, INC. | CLARK, RYAN T | 3794 | DP | Non-Final OA | — | Pending | Oct 29, 2024 |
| 18890466 | MOVING TARGETS ROUTE SIMULATOR QUARTERBACK GAME | Mao, Shiwei | ZHANG, YINGCHUAN | 3711 | §102§103 | Non-Final OA | — | Pending | Sep 19, 2024 |
| 18792154 | LNG LIQUEFACTION SYSTEM AND PROCESS | NuBlu Innovations, LLC | PETTITT, JOHN F | 3763 | §103§112 | Non-Final OA | — | Pending | Aug 01, 2024 |
| 18680548 | FEL D 1 KNOCKOUTS AND ASSOCIATED COMPOSITIONS AND METHODS BASED ON CRISPR-CAS9 GENOMIC EDITING | Indoor Biotechnologies Inc. | WILSON, MICHAEL C | 1638 | §102§103§112 | Non-Final OA | — | Pending | May 31, 2024 |
| 18608958 | CYCLED PULSING TO MITIGATE THERMAL DAMAGE FOR MULTI-ELECTRODE IRREVERSIBLE ELECTROPORATION THERAPY | AngioDynamics, Inc. | PEFFLEY, MICHAEL F | 3794 | §103 | Final Rejection | 43d overdue | Pending | Mar 19, 2024 |
| 18417748 | METHOD OF INITIATING AND ESCALATING SOTALOL HYDROCHLORIDE DOSING | AltaThera Pharmaceuticals LLC | BARSKY, JARED | 1628 | §103 | Final Rejection | 121d overdue | Pending | Jan 19, 2024 |
| 18404473 | DEVICES, SYSTEMS, AND METHODS FOR REAL-TIME MONITORING OF ELECTROPHYSICAL EFFECTS DURING TISSUE TREATMENT | VIRGINIA TECH INTELLECTUAL PROPERTIES, INC. | LANNU, JOSHUA DARYL DEANON | 3791 | §112 | Non-Final OA | — | Pending | Jan 04, 2024 |
| 18348605 | IMMUNOTHERAPEUTIC METHODS USING ELECTROPORATION | VIRGINIA TECH INTELLECTUAL PROPERTIES, INC. | PEFFLEY, MICHAEL F | 3794 | §103§112 | Non-Final OA | — | Pending | Jul 07, 2023 |
| 18315233 | LNG Liquefaction System and Process | High Roller E & C, LLC | KING, BRIAN M | 3763 | §103§112 | Final Rejection | 41d | Pending | May 10, 2023 |
| 18126561 | METHODS OF ADMINISTERING SOTALOL HYDROCHLORIDE | AltaThera Pharmaceuticals LLC | BARSKY, JARED | 1628 | §103 | Final Rejection | 125d overdue | Pending | Mar 27, 2023 |
| 17787773 | COMPOSITIONS AND METHODS FOR OOCYTE-SPECIFIC CONTRACEPTION | David Kroeger | COOK, LISA V | 1642 | §112 | Non-Final OA | — | Pending | Jun 21, 2022 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial66.3% of resolved applications prosecuted by New River Valley Intellectual were allowed, across 406 applications in USPTO records.
4.16 office actions per allowed application on average.
11 pending office actions as of October 2026, for 8 clients, before 9 examiners in 7 art units.
